Regeneron Starts Phase 3 Trial of its COVID-19 Dual Antibody Cocktail

Regeneron has started late-stage trials to evaluate the effectiveness of REGN-COV2, its dual antibody cocktail
$REGN $LLY $JNJ $IMV $EBS $ALNY #treatment #investment https://t.co/ArbEsrk7Gk https://t.co/pB8ECqhdfE